Skip navigation

China state media says 18 more detained in GSK probe

BEIJING (Reuters) - At least 18 more people have been detained in China in connection with a corruption scandal involving British drugmaker GlaxoSmithKline, state media reported, giving more details on a probe which has rocked the company. Full story

GSK appoints new head of China business

GlaxoSmithKline has named a new chief for its operations in China amid an investigation there for possible bribery of doctors, the drug manufacturer said Thursday. Full story

GSK replaces China chief amid corruption scandal

LONDON (Reuters) - GlaxoSmithKline has appointed one of its top European executives as the new head of operations in China, amid a corruption scandal there that has rocked Britain's biggest drug maker. Full story

Glaxo appoints law firm Ropes & Gray for China review

LONDON (Reuters) - GlaxoSmithKline <GSK.L> has appointed international law firm Ropes & Gray to carry out an independent review into alleged corruption by senior executives in its Chinese business, a spokesman for the drugmaker said. Full story

GlaxoSmithKline China charges update

   CNBC's Eunice Yoon discusses the damage control coming out of GlaxoSmithKline, which says the charges out of China were disappointing and the company is commissioning its own review.

News Summary: GSK cites possible China violations

BRIBERY PROBE: GlaxoSmithKline, which is target of a bribery probe in China, said Monday some executives may have broken the law. Full story

Sponsored Links

Articles

Glaxo says executives appear to have broken Chinese law

GSK boss to address China scandal at quarterly results: sources

GSK sends three executives to China to handle crisis

China halts travel agency's business over GSK case: report

China blocks GSK finance head from leaving country

News Summary: China IDs suspects in bribery probe

GSK examines Botox sales tactics used in China

China probes pricing at drugmakers including GSK, Merck

China probes British drugmaker GSK: report

Chinese police investigating local GlaxoSmithKline staff: report

Video

  GlaxoSmithKline faces charges in China

Some GSK exectuives appear to have broken Chinese law. There's a battle going on between the Chinese government and Glaxosmithkline, and it may be spurred by high drug prices, reports CNBC's Eunice Yoon.

  China GSK crackdown unnerves business community

China detained and questioned an executive of GlaxoSmithKline, amid an ongoing bribery investigation, reports CNBC's Eunice Yoon.

  Glaxo's CEO Predicts Growth in 2013

Andrew Witty, CEO of GlaxoSmithKline, discusses his company's 2012 earnings and explains why he is optimistic about the company's restructuring plans in Europe.

advertisement | ad info

Related Photos

File photo of a Chinese national flag in front of a GlaxoSmithKline office building in Shanghai
File photo of a Chinese national flag in front of a GlaxoSmithKline office building in Shanghai

A Chinese national flag flutters in front of a GlaxoSmithKline office building in Shanghai, in this July 12, 2013 file photo. The detention by Chinese authorities of a British corporate investigator and his American wife in the wake of a corruption probe into pharmaceutical giant GlaxoSmithKline ha

File photo of an employee walking into a GlaxoSmithKline office in Beijing
File photo of an employee walking into a GlaxoSmithKline office in Beijing

An employee walks into a GlaxoSmithKline office in Beijing, in this July 19, 2013 file photo. The detention by Chinese authorities of a British corporate investigator and his American wife in the wake of a corruption probe into pharmaceutical giant GlaxoSmithKline has had a chilling effect on other

The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013.REUTERS/Luke MacGregor
The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013.REUTERS/Luke MacGregor

The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013.REUTERS/Luke MacGregor

The GlaxoSmithKline building is pictured in Hounslow, west London
The GlaxoSmithKline building is pictured in Hounslow, west London

The GlaxoSmithKline building is pictured in Hounslow, west London June 18, 2013. REUTERS/Luke MacGregor